GUENTHER PORPHYRIA

Guenther Porphyria is a type of erythropoietic porphyria that occurs at birth. In Greek, porphura means “to bleed.” Moreover, porphura implies “purple pigment,” indicating that the tone of an individual’s body fluid alters when they have Gunther’s Porphyria.

A lack of the enzyme uroporphyrinogen cosynthase causes this rare autosomal passive metabolic disease that affects heme. It’s unusual, having a prevalence of fewer than one in a million. Also, Gunther’s disease has been linked to anemia in fetuses before birth. Patients in lesser cases did not show any symptoms until they were adults. 

TYPES

  • Harderoporphyria
  • Erythropoietic protoporphyria
  • Hereditary coproporphyria
  • Variegate porphyria

SYMPTOMS

  • Hypersensitivity to sunlight
  • Photosensitivity
  • Edema
  • Erythema
  • Vesicles or bullae
  • Hyperpigmentation
  • Erythrodontia
  • Hypertrichosis
  • Anemia

DIAGNOSIS

There are four steps to determining whether or not you have porphyria:

  • A detailed history (including family history) and physical examination are conducted first, with specific care given to sun-exposed skin. 
  • Measuring porphyrins and precursors in the urine, feces, and blood is necessary.
  • Measurement of efficiency of individual enzymes in the heme production pathway, as well as DNA and mutational investigations, can be done in specialized labs.
  • The efficiency of Uroporphyrinogen III, the fourth enzyme in the heme production footpath, will be significantly reduced in CEP. 

TREATMENT

Guenther porphyria can be treated in a variety of methods. These are some of them:

Reduce your exposure to the sun. Several sunscreens, such as equatorial sunscreens, have been found to serve as a protection due to light-reflective ingredients such as zinc oxide and titanium dioxide.

Physical impediments. To protect patients with Gunther’s illness by blocking UV and visible light wavelengths. They should  also wear protective gear to shield for sun protection. 

Oral beta-carotene, activated charcoal and cholestyramine. Disrupt and prevent the resorption of porphyrins in the body. These oral therapies are unrealistic since they demand an unusually big quantity of medicine and are consequently ineffective.

Transfusions of erythrocytes. This is done to effectively measure in lowering erythropoiesis and circulating porphyrin levels to reduce the manifestation of the disorder.

Topical lubrication. This aids in the relief of dry eye symptoms and the improvement of vision. Surgery would be a more invasive technique to assist treat Gunther’s condition.

Related Articles

TETRALOGY OF FALLOT

Overview and FactsTypes and SymptomsDiagnosis & MedicationsOverview and Facts Tetralogy of Fallot is a congenital heart defect that affects the [...]

TRICHINOSIS

Overview and FactsTypes and SymptomsDiagnosis & MedicationsOverview and Facts Trichinosis, also known as trichinellosis, is a parasitic infection caused by [...]

TRIGEMINAL NEURALGIA

Overview and FactsTypes and SymptomsDiagnosis & MedicationsOverview and Facts Trigeminal neuralgia is a neurological condition characterized by severe facial pain. [...]